FIELD: chemical-pharmaceutical industry. SUBSTANCE: method involves the use of the lyophilized genetic-engineering alpha-2-interferon at concentration 1×105-1×106 IU. Filling agent: sterile lactose, binding agent, stabilizing agent, sterile calcium stearate and sucrose. Coating is sprayed on tablet core in the air flow. Coating is a solution of acetylcellulose and castor oil in mixture with acetone and alcohol. EFFECT: improved method of preparing. 2 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBLINGUAL TABLET MEDICINAL PREPARATION COMPRISING ALPHA- INTERFERON AND METHOD FOR ITS PREPARING | 2003 |
|
RU2234939C1 |
| TABLETED INTERFERON PREPARATION FOR ORAL USE | 1999 |
|
RU2175554C2 |
| SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
| METHOD OF PREPARING PERORAL MEDICINAL FORM OF CYTOKINE (ITS VARIANTS) | 1993 |
|
RU2060729C1 |
| METHOD FOR PREPARING RECOMBINANT INTERFERON ALPHA-2b AND INTERFERON-CONTAINING PREPARATION (VARIANTS) | 2005 |
|
RU2294372C1 |
| VETERINARY COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2B, TOCOPHEROL ACETATE AND ASCORBIC ACID, BASED VETERINARY DRUG PREPARATION MULTIFERON AND USE OF DRUG PREPARATION MULTIFERON AS ANTIVIRAL AND IMMUNOMODULATORY AGENT IN VACCINATION SCHEDULES FOR YOUNG AGRICULTURAL ANIMALS | 2011 |
|
RU2481854C2 |
| METHOD FOR PREPARING ALPHA-FETOPROTEIN PREPARATION TABLET | 2005 |
|
RU2319479C2 |
| PREPARATION BASED UPON HUMAN RECOMBINANT ALPHA-2-INTERFERON FOR INJECTIONS IN DRY LYOPHILIZED FORM | 2002 |
|
RU2236866C2 |
| ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
| ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457855C2 |
